cIAPs promote the proteasomal degradation of mutant SOD1 linked to familial amyotrophic lateral sclerosis

Although the ubiquitin–proteasome system is believed to play an important role in the pathogenesis of familial amyotrophic lateral sclerosis (FALS), caused by mutations in Cu/Zn-superoxide dismutase 1 (SOD1), the mechanism of how mutant SOD1 protein is regulated in cells is still poorly understood....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2016-11, Vol.480 (3), p.422-428
Hauptverfasser: Choi, Jin Sun, Kim, Kidae, Lee, Do Hee, Cho, Sayeon, Ha, Jae Du, Park, Byoung Chul, Kim, Sunhong, Park, Sung Goo, Kim, Jeong-Hoon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although the ubiquitin–proteasome system is believed to play an important role in the pathogenesis of familial amyotrophic lateral sclerosis (FALS), caused by mutations in Cu/Zn-superoxide dismutase 1 (SOD1), the mechanism of how mutant SOD1 protein is regulated in cells is still poorly understood. Here we have demonstrated that cellular inhibitor of apoptosis proteins (cIAPs) are specifically associated with FALS-linked mutant SOD1 (mSOD1) and that this interaction promotes the ubiquitin-dependent proteasomal degradation of mutant SOD1. By utilizing cumate inducible SOD1 cells, we also showed that knock-down or pharmacologic depletion of cIAPs leads to H2O2 induced cytotoxicity in mSOD1 expressing cells. Altogether, our results reveal a novel role of cIAPs in FALS-associated mutant SOD1 regulation. •cIAPs selectively interact with FALS-linked mutant SOD1.•cIAPs-mutant SOD1 interaction promotes ubiquitination and degradation of mutant SOD1.•Knock-down or pharmacologic depletion of cIAPs leads to H2O2 induced cytotoxicity in mutant SOD1 expressing cells.•Our results reveal a novel role of cIAPs in FALS-associated mutant SOD1 regulation.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2016.10.065